DrugPatentWatch Database Preview
Assertio Company Profile
What is the competitive landscape for ASSERTIO, and what generic alternatives to ASSERTIO drugs are available?
ASSERTIO has three approved drugs.
There are nineteen US patents protecting ASSERTIO drugs.
There are one hundred and four patent family members on ASSERTIO drugs in thirty-one countries.
Summary for Assertio
| International Patents: | 104 |
| US Patents: | 19 |
| Tradenames: | 3 |
| Ingredients: | 2 |
| NDAs: | 3 |
Drugs and US Patents for Assertio
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assertio | GRALISE | gabapentin | TABLET;ORAL | 022544-001 | Jan 28, 2011 | BX | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Assertio | GRALISE | gabapentin | TABLET;ORAL | 022544-001 | Jan 28, 2011 | BX | RX | Yes | Yes | 7,731,989 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | ||
| Assertio | GRALISE | gabapentin | TABLET;ORAL | 022544-002 | Jan 28, 2011 | BX | RX | Yes | Yes | 6,723,340 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | ||
| Assertio | CAMBIA | diclofenac potassium | FOR SOLUTION;ORAL | 022165-001 | Jun 17, 2009 | AB | RX | Yes | Yes | 7,759,394 | ➤ Try a Free Trial | Y | Y | ➤ Try a Free Trial | |
| Assertio | GRALISE | gabapentin | TABLET;ORAL | 022544-002 | Jan 28, 2011 | BX | RX | Yes | Yes | 6,488,962 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | ||
| Assertio | CAMBIA | diclofenac potassium | FOR SOLUTION;ORAL | 022165-001 | Jun 17, 2009 | AB | RX | Yes | Yes | 8,927,604 | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Assertio
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Assertio | GRALISE | gabapentin | TABLET;ORAL | 022544-002 | Jan 28, 2011 | 6,635,280 | ➤ Try a Free Trial |
| Assertio | ZIPSOR | diclofenac potassium | CAPSULE;ORAL | 022202-001 | Jun 16, 2009 | 6,287,594 | ➤ Try a Free Trial |
| Assertio | GRALISE | gabapentin | TABLET;ORAL | 022544-001 | Jan 28, 2011 | 6,340,475 | ➤ Try a Free Trial |
| Assertio | GRALISE | gabapentin | TABLET;ORAL | 022544-001 | Jan 28, 2011 | 6,635,280 | ➤ Try a Free Trial |
| Assertio | GRALISE | gabapentin | TABLET;ORAL | 022544-002 | Jan 28, 2011 | 6,340,475 | ➤ Try a Free Trial |
| Assertio | CAMBIA | diclofenac potassium | FOR SOLUTION;ORAL | 022165-001 | Jun 17, 2009 | 6,974,595 | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for ASSERTIO drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Potassium Oral Solution (Sachet) | 50 mg | ➤ Subscribe | 2011-01-24 |
| ➤ Subscribe | Capsules | 25 mg | ➤ Subscribe | 2012-11-14 |
| ➤ Subscribe | Tablets | 300 mg and 600 mg | ➤ Subscribe | 2011-10-31 |
International Patents for Assertio Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Germany | 60101581 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 0113897 | ➤ Try a Free Trial |
| Australia | 2002348828 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 2006015294 | ➤ Try a Free Trial |
| European Patent Office | 1976503 | ➤ Try a Free Trial |
| South Korea | 20020050223 | ➤ Try a Free Trial |
| Country | Patent Number | Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
